Caribou Biosciences, Inc.

NASDAQ:CRBU

1.8 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -102.07-99.421-66.923-34.308-23.431
Depreciation & Amortization 3.5251.6220.9840.90.751
Deferred Income Tax 0-0.095-1.5220.8030
Stock Based Compensation 13.7511.7163.4491.0021.234
Change In Working Capital -7.318-4.20429.0670.177-8.267
Accounts Receivables 0.8050.951-1.003-0.1460.617
Inventory 00-2.21.355-2.224
Accounts Payables 1.819-2.7211.1390.0431.176
Other Working Capital -9.942-2.43431.131-1.075-7.836
Other Non Cash Items -1.178-0.5842.426-1.789-2.293
Operating Cash Flow -93.291-90.966-32.519-33.215-32.006
Investing Activities:
Investments In Property Plant And Equipment -11.613-7.054-3.121-1.315-0.884
Acquisitions Net 00.600.010
Purchases Of Investments -394.758-339.063-173.276-0.010
Sales Maturities Of Investments 338.188252.86807.66828.117
Other Investing Activites 0-0.6-10.0128.117
Investing Cash Flow -68.183-93.249-176.3976.36327.233
Financing Activities:
Debt Repayment 001.0311.465-0.045
Common Stock Issued 152.722.133321.020.270.217
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities 1.5782.133111.3780.270.217
Financing Cash Flow 154.2982.133433.4291.7350.172
Other Information:
Effect Of Forex Changes On Cash 00000
Net Change In Cash -7.176-182.082224.513-25.117-4.601
Cash At End Of Period 51.20858.384240.46615.95341.07